Advertisement
News
Advertisement

CRi Launches the TRIO™ Multispectral Imaging System for Multi-Analyte Investigation in Tissue

Tue, 11/09/2010 - 4:35am
Bio-Medicine.Org

WOBURN, Mass., Nov. 9, 2010 /PRNewswire/ -- Cambridge Research & Instrumentation, Inc. (CRi), a leader in multicolor imaging solutions for preclinical and clinical research, today announced the newest addition to the award-winning Nuance™ multispectral imaging product family for multicolor tissue and cell-based imaging. The TRIO system is compact, multipurpose and affordable, offering a simplified interface and versatile design to fit any microscope with a camera-mount. This newest offering strengthens CRi's objective to offer a comprehensive and intuitive solution that enables customers from basic research through pre-clinical drug discovery to reveal correlations between protein expression in intact tissue and clinical outcomes.

(Photo: http://photos.prnewswire.com/prnh/20101109/NE97171 )

(Photo: http://www.newscom.com/cgi-bin/prnh/20101109/NE97171 )

Multi-analyte detection from intact tissue and cells often poses a challenge since overlapping signals and the sample's own background autofluorescence can mask critical information. TRIO's multispectral imaging technology found in all of CRi's multispectral systems effectively unmixes overlapping labels in fluorescence or brightfield samples. It has a new easy-to-use software interface designed to preclude the need to have expert-level knowledge of multispectral imaging, a common hurdle that faces many scientists who want to be able to image multiple markers from a single tissue sample. TRIO's interface ensures that data can be obtained in a matter of minutes.

"Detecting multiple markers in intact tissue sections and in individual tumor cells is an important component of targeted drug and molecular diagnostic development," said Darren Lee, Vice President of Marketing at CRi.  "We understand the hurdles associated with doing multilabel imagin

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading